BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35137378)

  • 1. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer.
    Ortega MA; Pekarek L; Garcia-Montero C; Fraile-Martinez O; Saez MA; Asúnsolo A; Alvarez-Mon MA; Monserrat J; Coca S; Toledo-Lobo MV; García-Honduvilla N; Albillos A; Buján J; Alvarez-Mon M; Guijarro LG
    Histol Histopathol; 2022 May; 37(5):449-459. PubMed ID: 35137378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer.
    Ortega MA; Fraile-Martinez O; Pekarek L; García-Montero C; Alvarez-Mon MA; Castellanos AJ; García-Honduvilla N; Buján J; Alvarez-Mon M; Sáez MA; Guijarro LG; Asúnsolo A
    Antioxidants (Basel); 2022 Apr; 11(4):. PubMed ID: 35453444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated preoperative levels of CA 19-9 and CA 125 predicts overall survival time in the pancreatic adenocarcinoma. Single institution series.
    Hogendorf P; Skulimowski A; Durczyński A; Kumor A; Poznańska G; Poznańska A; Oleśna A; Rut J; Øvereng Juliebø S; Szmiel A; Strzelczyk J
    Pol Przegl Chir; 2020 Apr; 92(3):32-38. PubMed ID: 32759395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
    Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
    Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
    Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
    Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic factors of pancreatic cancer can be different according to clinical stages.
    Kim YJ; Seo DW; Pack KM; Jeong E; Kim SC; Han DJ; Lee SS; Lee SK; Kim MH
    Korean J Gastroenterol; 2008 Mar; 51(3):181-9. PubMed ID: 18451692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNIK serves as a novel biomarker associated with poor prognosis in patients with pancreatic cancer.
    Zhang Y; Jiang H; Qin M; Su X; Cao Z; Wang J
    Tumour Biol; 2016 Jan; 37(1):1035-40. PubMed ID: 26269113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Hamada C; Baba H
    World J Surg; 2006 Feb; 30(2):213-8. PubMed ID: 16425074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
    Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
    World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between the index of lymph node metastasis and the prognosis of pancreatic cancer patients after R0 resection].
    Ren H; Wang CF
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):474-479. PubMed ID: 32575943
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer.
    Jiang W; Bai W; Li J; Liu J; Zhao K; Ren L
    Int J Cancer; 2021 Feb; 148(4):1006-1013. PubMed ID: 32914874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma.
    Jiang NY; Woda BA; Banner BF; Whalen GF; Dresser KA; Lu D
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1648-52. PubMed ID: 18628415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
    Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
    Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of YKL-40 Predicts Poor Prognosis in Patients Undergoing Curative Resection of Pancreatic Cancer.
    Chen HT; Zheng JM; Zhang YZ; Yang M; Wang YL; Man XH; Chen Y; Cai QC; Li ZS
    Pancreas; 2017 Mar; 46(3):323-334. PubMed ID: 28099248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients].
    Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.
    Yang C; Cheng H; Luo G; Lu Y; Guo M; Jin K; Wang Z; Yu X; Liu C
    Eur J Surg Oncol; 2017 Nov; 43(11):2112-2118. PubMed ID: 28802662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.